Non-light-chain immunoglobulin amyloidosis: Time to expand or refine the spectrum to include light+heavy chain amyloidosis?

18Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Among the various systemic amyloidoses, deposits derived from the immunoglobulin light chain (AL) account for 85% of cases. In this issue, Nasr et al. report 16 cases of renal heavy and light+heavy chain amyloidosis and compare them with renal light chain amyloidosis. While additional studies are needed to shed light on the heavy and light+heavy chain amyloidoses, several observations by the authors suggest important practical implications, including differences in clinical picture, prognosis and pathologic diagnosis. © 2012 International Society of Nephrology.

Cite

CITATION STYLE

APA

Picken, M. M. (2013). Non-light-chain immunoglobulin amyloidosis: Time to expand or refine the spectrum to include light+heavy chain amyloidosis? Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2012.433

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free